Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Neuroendocrine-derived peptides promote prostate cancer cell survival through activation of IGF-1R signaling.

DaSilva JO, Amorino GP, Casarez EV, Pemberton B, Parsons SJ.

Prostate. 2013 Jun;73(8):801-12. doi: 10.1002/pros.22624. Epub 2012 Nov 28.

2.

Inhibition of neurotensin receptor 1 selectively sensitizes prostate cancer to ionizing radiation.

Valerie NC, Casarez EV, Dasilva JO, Dunlap-Brown ME, Parsons SJ, Amorino GP, Dziegielewski J.

Cancer Res. 2011 Nov 1;71(21):6817-26. doi: 10.1158/0008-5472.CAN-11-1646. Epub 2011 Sep 8.

3.

Radiosensitization and modulation of p44/42 mitogen-activated protein kinase by 2-Methoxyestradiol in prostate cancer models.

Casarez EV, Dunlap-Brown ME, Conaway MR, Amorino GP.

Cancer Res. 2007 Sep 1;67(17):8316-24.

4.

Androgen-independent growth and tumorigenesis of prostate cancer cells are enhanced by the presence of PKA-differentiated neuroendocrine cells.

Deeble PD, Cox ME, Frierson HF Jr, Sikes RA, Palmer JB, Davidson RJ, Casarez EV, Amorino GP, Parsons SJ.

Cancer Res. 2007 Apr 15;67(8):3663-72.

5.

Neurotensin stimulates mitogenesis of prostate cancer cells through a novel c-Src/Stat5b pathway.

Amorino GP, Deeble PD, Parsons SJ.

Oncogene. 2007 Feb 1;26(5):745-56. Epub 2006 Jul 24.

PMID:
16862179
6.

Requirement of Tyr-992 and Tyr-1173 in phosphorylation of the epidermal growth factor receptor by ionizing radiation and modulation by SHP2.

Sturla LM, Amorino G, Alexander MS, Mikkelsen RB, Valerie K, Schmidt-Ullrichr RK.

J Biol Chem. 2005 Apr 15;280(15):14597-604. Epub 2005 Feb 11.

7.

Neuroendocrine cells in prostate cancer.

Amorino GP, Parsons SJ.

Crit Rev Eukaryot Gene Expr. 2004;14(4):287-300. Review.

PMID:
15663358
8.

ERBB receptor tyrosine kinases and cellular radiation responses.

Schmidt-Ullrich RK, Contessa JN, Lammering G, Amorino G, Lin PS.

Oncogene. 2003 Sep 1;22(37):5855-65. Review.

PMID:
12947392
9.

EGFRvIII-mediated radioresistance through a strong cytoprotective response.

Lammering G, Hewit TH, Valerie K, Contessa JN, Amorino GP, Dent P, Schmidt-Ullrich RK.

Oncogene. 2003 Aug 28;22(36):5545-53.

PMID:
12944901
10.

Dominant-negative cAMP-responsive element-binding protein inhibits proliferating cell nuclear antigen and DNA repair, leading to increased cellular radiosensitivity.

Amorino GP, Mikkelsen RB, Valerie K, Schmidt-Ullrich RK.

J Biol Chem. 2003 Aug 8;278(32):29394-9. Epub 2003 May 6.

11.

Bile acid regulation of C/EBPbeta, CREB, and c-Jun function, via the extracellular signal-regulated kinase and c-Jun NH2-terminal kinase pathways, modulates the apoptotic response of hepatocytes.

Qiao L, Han SI, Fang Y, Park JS, Gupta S, Gilfor D, Amorino G, Valerie K, Sealy L, Engelhardt JF, Grant S, Hylemon PB, Dent P.

Mol Cell Biol. 2003 May;23(9):3052-66.

12.

Stress and radiation-induced activation of multiple intracellular signaling pathways.

Dent P, Yacoub A, Contessa J, Caron R, Amorino G, Valerie K, Hagan MP, Grant S, Schmidt-Ullrich R.

Radiat Res. 2003 Mar;159(3):283-300. Review.

PMID:
12600231
13.

Epidermal growth factor receptor dependence of radiation-induced transcription factor activation in human breast carcinoma cells.

Amorino GP, Hamilton VM, Valerie K, Dent P, Lammering G, Schmidt-Ullrich RK.

Mol Biol Cell. 2002 Jul;13(7):2233-44.

15.
16.

The novel taxane analogs, BMS-184476 and BMS-188797, potentiate the effects of radiation therapy in vitro and in vivo against human lung cancer cells.

Kim JS, Amorino GP, Pyo H, Cao Q, Price JO, Choy H.

Int J Radiat Oncol Biol Phys. 2001 Oct 1;51(2):525-34.

PMID:
11567829
17.

Enhancement of tumor oxygenation and radiation response by the allosteric effector of hemoglobin, RSR13.

Amorino GP, Lee H, Holburn GE, Paschal CB, Hercules SK, Shyr Y, Steffen RP, Choy H.

Radiat Res. 2001 Sep;156(3):294-300.

PMID:
11500138
18.

Combined effects of the orally active cisplatin analog, JM216, and radiation in antitumor therapy.

Amorino GP, Mohr PJ, Hercules SK, Pyo H, Choy H.

Cancer Chemother Pharmacol. 2000;46(5):423-6.

PMID:
11127948
19.

Preclinical evaluation of the orally active camptothecin analog, RFS-2000 (9-nitro-20(S)-camptothecin) as a radiation enhancer.

Amorino GP, Hercules SK, Mohr PJ, Pyo H, Choy H.

Int J Radiat Oncol Biol Phys. 2000 May 1;47(2):503-9.

PMID:
10802379
20.

Enhancement of radiation effects in vitro by the estrogen metabolite 2-methoxyestradiol.

Amorino GP, Freeman ML, Choy H.

Radiat Res. 2000 Apr;153(4):384-91.

PMID:
10760997
21.

Radiopotentiation by the oral platinum agent, JM216: role of repair inhibition.

Amorino GP, Freeman ML, Carbone DP, Lebwohl DE, Choy H.

Int J Radiat Oncol Biol Phys. 1999 May 1;44(2):399-405.

PMID:
10760436
22.

Enhancement of radiation effects by combined docetaxel and carboplatin treatment in vitro.

Amorino GP, Hamilton VM, Choy H.

Radiat Oncol Investig. 1999;7(6):343-52.

PMID:
10644057
23.
24.
25.

Effects of hyperthermia on intracellular chloride.

Amorino GP, Fox MH.

J Membr Biol. 1996 Aug;152(3):217-22.

PMID:
8672083
26.

Supplemental Content

Loading ...
Support Center